Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.B1 (
angiotensin-converting enzyme 2
)
1,025
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The COVID-19 pandemic has swept over the world in the past months, causing significant loss of life and consequences to human health. Although numerous drug and vaccine developments efforts are underway, many questions remain outstanding on the mechanism of SARS-CoV-2 viral association to
angiotensin-converting enzyme 2
(
ACE2
), its main host receptor, and entry in the cell. Structural and biophysical studies indicate some degree of flexibility in the viral extracellular Spike glycoprotein and at the receptor binding domain-receptor interface, suggesting a role in infection. Here, we perform all-atom molecular dynamics simulations of the glycosylated, full-length membrane-bound
ACE2
receptor, in both an apo and spike receptor binding domain (RBD) bound state, in order to probe the intrinsic dynamics of the
ACE2
receptor in the context of the cell surface. A large degree of fluctuation in the full length structure is observed, indicating hinge bending motions at the linker region connecting the head to the transmembrane helix, while still not disrupting the
ACE2
homodimer
or
ACE2
-RBD interfaces. This flexibility translates into an ensemble of
ACE2
homodimer
conformations that could sterically accommodate binding of the spike trimer to more than one
ACE2
homodimer
, and suggests a mechanical contribution of the host receptor towards the large spike conformational changes required for cell fusion. This work presents further structural and functional insights into the role of
ACE2
in viral infection that can be exploited for the rational design of effective SARS-CoV-2 therapeutics.
...
PMID:The flexibility of ACE2 in the context of SARS-CoV-2 infection. 3318 80
The coronavirus disease 2019 (COVID-19) pandemic has swept over the world in the past months, causing significant loss of life and consequences to human health. Although numerous drug and vaccine development efforts are underway, there are many outstanding questions on the mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral association to
angiotensin-converting enzyme 2
(
ACE2
), its main host receptor, and host cell entry. Structural and biophysical studies indicate some degree of flexibility in the viral extracellular spike glycoprotein and at the receptor-binding domain (RBD)-receptor interface, suggesting a role in infection. Here, we perform explicitly solvated, all-atom, molecular dynamics simulations of the glycosylated, full-length, membrane-bound
ACE2
receptor in both an apo and spike RBD-bound state to probe the intrinsic dynamics of the
ACE2
receptor in the context of the cell surface. A large degree of fluctuation in the full-length structure is observed, indicating hinge bending motions at the linker region connecting the head to the transmembrane helix while still not disrupting the
ACE2
homodimer
or
ACE2
-RBD interfaces. This flexibility translates into an ensemble of
ACE2
homodimer
conformations that could sterically accommodate binding of the spike trimer to more than one
ACE2
homodimer
and suggests a mechanical contribution of the host receptor toward the large spike conformational changes required for cell fusion. This work presents further structural and functional insights into the role of
ACE2
in viral infection that can potentially be exploited for the rational design of effective SARS-CoV-2 therapeutics.
...
PMID:The Flexibility of ACE2 in the Context of SARS-CoV-2 Infection. 3299 69